Log In
BCIQ
Print this Print this
 

Tubulin

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Tubulin

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 6 Marketed, 9 Approved, 2 Phase III, 1 Phase III, 6 Phase II/III, 1 Phase II, 2 Phase II, 16 Phase I/II, 9 Phase I, 1 Phase I, 18 IND, 1 IND, 1 Preclinical, 1 Preclinical, 1 Preclinical, 9 Preclinical, 1
Phase of DevelopmentPreclinicalINDPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIApprovedMarketed
Autoimmune

1

1

-

-

-

-

-

-

-

Cancer

9

1

18

9

16

1

6

2

9

Cardiovascular

-

-

-

-

-

-

-

-

6

Endocrine / Metabolic

-

-

-

-

-

-

-

-

1

Neurology

1

-

1

-

2

-

1

-

-

Ophthalmic

1

-

-

-

-

-

-

-

-




 Products Targeting Tubulin
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

19

$4,246.5M

$1,949.2M

$197.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today